2023 ASCO Annual Meeting
“With an influx of approved targeted therapy oncology products, life sciences organizations need to ensure they are optimizing placement on care pathways to reflect the latest evidence, promote high-quality care, and improve outcomes. ”
ASCO 2023
Meet Our
Experts
President
Executive Vice President, Life Sciences Strategy and Growth
Practice Director, Market Access
Practice Director, Evidence & Strategy
Principal, Policy
Associate Principal, Market Access
Our experts will be available to discuss these priority topics
Navigating a Complex Patient, Provider, and Payer Environment
An increasingly complex oncology market requires a broad perspective to navigate successfully. Our team can help develop strategies focused on demonstrating value, assessing oncology practice-level utilization and quality performance, and quantifying patient affordability exposure for new treatments.
Inflation Reduction Act (IRA) Implementation
Inflation-based rebates, Medicare price negotiation, Part D benefit design, and other IRA policies will have a profound impact on healthcare stakeholders. Avalere can help evaluate these policies’ effects and develop strategies for product development and investment decisions, manufacturer contracting strategies, plan formulary and benefit design, and ensuring patient access to medications.
Patient-Centric Evidence Development
Increasingly, payers and providers are demanding non-traditional evidence to answer questions about how different types of patients fare in real-world oncology treatment settings. Our experts can share perspectives on topics like defining care, elevating the patient perspective, and meaningfully incorporating health equity and social determinants of health considerations into evidence generation.
